Morgan Stanley
-
CNP Assurances and Helvetia Europe have added to issuance momentum in the insurance sector, giving investors the chance to put money into subordinated capital. The tier two bonds showed that ‘the market is back in shape’, said one deal arranger. -
Agora is looking to raise up to $315m from its Nasdaq IPO, having begun bookbuilding for the deal.
-
Drug developer SK Biopharmaceuticals priced its IPO high last Friday, netting W959.3bn ($792m), according to a source close to the deal.
-
Kangji Medical Holdings has bagged HK$3.59bn ($464.2m) after pricing its Hong Kong listing at the top of the marketed range.
-
Hygeia Healthcare Holdings is on track to price its Hong Kong IPO at the top of the marketed range, according to a source close to the deal.
-
Philippine fast food operator Jollibee Foods Corp made a quick return to the dollar market on Thursday, attracting investors to its dual-tranche bond despite the impact the coronavirus has had on its business.
-
China Pacific Insurance (Group) Co became the second company to use the London-Shanghai Stock Connect scheme this week, listing Global Depository Receipts on London’s bourse. The deal could spur further London-bound issuance by Chinese firms, according to bankers in the UK and Asia. Jonathan Breen and Aidan Gregory report.
-
Chinese real estate developer Zhongliang Holdings Group Co took $250m from a sub-one year bond on Wednesday, prioritising size over price for the deal.
-
Barrick Gold Corp has raised HK$1.63bn ($209.7m) after paring most of its stake in Chinese firm Shandong Gold Corp.
-
Chinese automaker Dongfeng Nissan sold a Rmb4bn ($564m) four tranche auto ABS transaction on Tuesday. The deal got strong demand, following a recent spike in onshore yields.
-
China Pacific Insurance (Group) Co has raised $1.81bn from its listing of Global Depository Receipts, becoming just the second company to use the London-Shanghai Stock Connect scheme.
-
Europe’s corporate bond market burst into life on Tuesday with more than 10 primary deals on screens, as the US Federal Reserve’s plans to buy individual bonds brushed aside fears of a resurgence of Covid-19.
